|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$24,000
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-08
|
$26,966,030
|
$1,887,622
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S1
|
$1,499,003
|
$104,930
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S2
|
$39,636
|
$2,775
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S3
|
$39,636
|
$2,775
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-08
|
$5,935,261
|
$415,468
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
|
5K08CA123100-05
|
$139,320
|
$139,320
|
ATTIYEH, EDWARD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Iowa Oncology Research Association
|
5U10CA035101-25
|
$685,544
|
$6,855
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Focal Adhesion Kinase (FAK) in Human Neuroblastoma
|
5K08CA118178-05
|
$134,477
|
$134,477
|
BEIERLE, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
2U10CA063844-17
|
$837,264
|
$8,373
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
3U10CA063844-17S1
|
$100,000
|
$1,000
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-27
|
$428,852
|
$4,289
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Molecular Genetic Analysis of Human Neuroblastoma
|
5R01CA039771-22
|
$388,815
|
$388,815
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
5R01CA094194-08
|
$387,333
|
$387,333
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
|
5R01CA079756-10
|
$238,892
|
$71,668
|
BUCHBERG, Arthur
|
THOMAS JEFFERSON UNIVERSITY
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
2U10CA035178-27
|
$1,358,665
|
$13,587
|
BURY, MARTIN
|
SPECTRUM HEALTH HOSPITALS
|
|
Beaumont Community Clinical Oncology Program
|
2U10CA095860-09
|
$929,588
|
$9,296
|
Chmielewski, Gary
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-09S1
|
$200,000
|
$2,000
|
Chmielewski, Gary
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Translational Genomics of MicroRNAs in Neuroblastoma
|
5K08CA136979-02
|
$158,005
|
$158,005
|
Cole, Kristina
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Development of Novel Inhibitors of Ganglioside Biosynthesis
|
3R44CA119801-03S1
|
$106,461
|
$36,197
|
CRAWFORD, BRETT
|
ZACHARON PHARMACEUTICALS, INC.
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$412,658
|
$41,266
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$412,658
|
$41,266
|
Daar, Ira
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$2,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$80,346
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-03
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
5R01CA124982-04
|
$279,300
|
$279,300
|
DING, HAN-FEI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Copy number variations (CNVs) in neuroblastoma
|
1K99CA151869-01
|
$170,826
|
$170,826
|
Diskin, Sharon
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Improving T-cell therapies for neuroblastoma
|
1R01CA142636-01
|
$280,644
|
$280,644
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S4
|
$6,545,448
|
$130,909
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S5
|
$99,753
|
$1,995
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S6
|
$253,376
|
$5,068
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Nevada Cancer Research Foundation-Community Clinical Oncology Program
|
5U10CA035421-27
|
$649,759
|
$6,498
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Center of Nanotechnology for Treatment, Understanding, *
|
3U54CA119335-05S6
|
$107,008
|
$5,350
|
ESENER, SADIK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5K99CA134743-02
|
$140,940
|
$28,188
|
Feng, Hui
|
DANA-FARBER CANCER INSTITUTE
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Symptom Cluster Subgroups in Adult Survivors of Childhood Cancers
|
5R01CA136912-02
|
$239,033
|
$23,903
|
Finnegan, Lorna
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Quality Assurance Review Center
|
5U10CA029511-31
|
$1,844,678
|
$36,894
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Radiologial Physics Center
|
5U10CA010953-42
|
$2,462,413
|
$49,248
|
Followill, David
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
3R01CA129831-03S1
|
$93,600
|
$30,888
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
5R01CA129831-03
|
$314,250
|
$103,703
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
|
5K08CA128925-04
|
$139,320
|
$139,320
|
Goldsmith, Kelly
|
EMORY UNIVERSITY
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$12,027
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-32
|
$2,297,459
|
$505,441
|
Hendershot, Linda
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
MYCN Function in Neuroblastoma
|
5R01CA127571-03
|
$326,610
|
$326,610
|
IKEGAKI, NAOHIKO
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Cancer Center Support (Core) Grant
|
2P30CA014051-39
|
$4,057,188
|
$40,572
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
MCG Minority-Based Community Clinical Oncology Program
|
3U10CA107586-07S1
|
$100,784
|
$1,008
|
Jillella, Anand
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
MCG Minority-Based Community Clinical Oncology Program
|
5U10CA107586-07
|
$509,490
|
$5,095
|
Jillella, Anand
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-07
|
$304,318
|
$304,318
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
$9,995
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
$7,398
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Neuroblastoma for this search: $20,050,819
|